Released Mar 18, 2013, after the close
10-Q filed Mar 18, 2013, 46 days after period end · 0001354488-13-001293
Q1 2013 · 10-Q
Revenue—
Net Income$1.05M$1.05M −8.1% vs Q1 2012−2.2% vs Q4 2012
EPS Diluted$0.05$0.05 −8.0% vs Q1 2012no prior Q4 2012 on file
Gross Profit$2,566,768+14.2%
Operating Income$1,290,304−5.3%
Operating Cash Flow$442,986N/M
Free Cash Flowderived$361,531N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Net Income | $1.05M | $1.15M | $356.26K |
| EPS Diluted | $0.05 | $0.05 | $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR